INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
INSIDE PHARMA, 21 JAN 2022—WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY

INSIDE PHARMA, 21 JAN 2022—WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY

Now we know what we know on the dangers of mRNA, time to stop the injections!!!

Hedley Rees's avatar
Hedley Rees
Nov 22, 2023
∙ Paid
8

Share this post

INSIDE PHARMA
INSIDE PHARMA
INSIDE PHARMA, 21 JAN 2022—WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY
2
Share

Share

WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY

Hot on the heels of the Pfizer/BioNTech SARS-CoV-2 injection comes the next candidates for mRNA treatment – Shingles.

In an article published in PHARMACEUTICAL TECHNOLOGY, titled Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles, January 6, 2022, the deal was described by Pfizer Worldwide Research, Development & Medical chief scientific officer and president Mikael Dolsten as so: “With t

his agreement, we continue on our journey of discovery together, by advancing mRNA technology to tackle another health challenge ripe for scientific innovation, supported by our world-class manufacturing network.”

Inside Pharma says:

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share